News and Events

IntraOp Medical Corporation and the University of Verona in Italy announced today the enrollment of the first patient in the PancFORT Trial: A phase II study of primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.

New clinical technology and preclinical Flash radiotherapy in one platform to advance research and treatments for cancer patients

New Technology and Research has potential to transform the fundamentals of radiation oncology unlocking new opportunities for cancer patients.

IntraOp and Lausanne University Hospital Announce Collaboration in FLASH radiotherapy

Study to demonstrate the superiority of a single treatment of electron-beam IORT compared with weeks of standard radiation therapy